Smiths Medical said yesterday that it won 510(k) clearance from the FDA for its CADD-Solis wireless ambulatory infusion pump.
The device can connect wirelessly with Smiths’ PharmGuard Server infusion management software, enabling clinicians to deploy updates and drug libraries to all pumps simultaneously, as well as remotely manage device performance and monitor drug dosing.
The wireless capability also allows healthcare workers to integrate infusion data to patient records and download reports to make better therapy decisions for each patient, the company reported.
Smiths’ pump is indicated for use with epidurals, peripheral nerve blocks and drug-delivery to the subarachnoid space, an intra-operative site, intra-arterial and subcutaneous use.
Last year, the company launched its wireless device in Canada, Australia, New Zealand, the UK and Ireland.